Nu Skin Enterprises Inc. (NUS - Free Report) has recently appointed Mark H. Lawrence as its new chief financial officer (CFO), who will take position from Mar 27. Lawrence will succeed Ritch Wood, who will now be the company’s chief executive officer (CEO), as announced in Dec 2016.
Ritch Wood will replace Truman Hunt, who has decided to leave the company in mid-2017 to take a three-year leadership assignment with the Mormon Church. Hunt had served the company as the president and CEO since 2003 and will now serve as the vice chairman of the board of directors. In addition, the company appointed Ryan Napierski as the company's president.
We observe that Nu Skin has been a disappointment since it reported weaker-than-expected fourth-quarter 2016 results on Feb 17. In fact, the company missed the earnings guidance provided in Dec 2016. In the said period, the stock declined 8.9% wider than the Zacks categorized Cosmetics & Toiletries industry’s dip of 1.3%.
In the fourth quarter of 2016, the beauty and wellness products company reported adjusted earnings of 79 cents, up 27.4% year over year. However, revenues declined 7.2% to $531.3 million, owing to the negative impact of currency. Product launch of approximately $50 million in the fourth quarter also impacted revenues negatively. It was also adversely impacted by $7 million of deferred revenues, primarily from a stronger-than-anticipated response to a promotion of ageLOC Me cartridges in China.
Nevertheless, the company reaffirmed its 2017 guidance. Though weak first-quarter 2017 guidance combined with the fourth-quarter 2016 revenues miss may weigh on the shares in the near term, the reaffirmed 2017 guidance along with improving comps in the second half of 2017 and an expected launch of LumiSpa in October, could be a catalyst for the stock and accelerate revenue growth.
Nu Skin currently has a Zacks Rank #3 (Hold).
Other Stocks to Consider
Some better-ranked food stocks in the industry include Lamb Weston Holdings Inc. (LW - Free Report) , ConAgra Foods, Inc. (CAG - Free Report) and Ingredion, Inc. (INGR - Free Report) .
Lamb Weston has long-term earnings growth rate of 3.24% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
ConAgra Foods and Ingredion, both carrying a Zacks Rank #2 (Buy), have growth rates of 8.00% and 11.00%, respectively.
8 Stocks with Huge Profit Potential
Just released: Driverless Cars: Your Roadmap to Mega-Profits Today. In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Nu Skin Enterprises Inc. (NUS - Free Report) has recently appointed Mark H. Lawrence as its new chief financial officer (CFO), who will take position from Mar 27. Lawrence will succeed Ritch Wood, who will now be the company’s chief executive officer (CEO), as announced in Dec 2016.
Ritch Wood will replace Truman Hunt, who has decided to leave the company in mid-2017 to take a three-year leadership assignment with the Mormon Church. Hunt had served the company as the president and CEO since 2003 and will now serve as the vice chairman of the board of directors. In addition, the company appointed Ryan Napierski as the company's president.
We observe that Nu Skin has been a disappointment since it reported weaker-than-expected fourth-quarter 2016 results on Feb 17. In fact, the company missed the earnings guidance provided in Dec 2016. In the said period, the stock declined 8.9% wider than the Zacks categorized Cosmetics & Toiletries industry’s dip of 1.3%.
In the fourth quarter of 2016, the beauty and wellness products company reported adjusted earnings of 79 cents, up 27.4% year over year. However, revenues declined 7.2% to $531.3 million, owing to the negative impact of currency. Product launch of approximately $50 million in the fourth quarter also impacted revenues negatively. It was also adversely impacted by $7 million of deferred revenues, primarily from a stronger-than-anticipated response to a promotion of ageLOC Me cartridges in China.
Nevertheless, the company reaffirmed its 2017 guidance. Though weak first-quarter 2017 guidance combined with the fourth-quarter 2016 revenues miss may weigh on the shares in the near term, the reaffirmed 2017 guidance along with improving comps in the second half of 2017 and an expected launch of LumiSpa in October, could be a catalyst for the stock and accelerate revenue growth.
Nu Skin currently has a Zacks Rank #3 (Hold).
Other Stocks to Consider
Some better-ranked food stocks in the industry include Lamb Weston Holdings Inc. (LW - Free Report) , ConAgra Foods, Inc. (CAG - Free Report) and Ingredion, Inc. (INGR - Free Report) .
Lamb Weston has long-term earnings growth rate of 3.24% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
ConAgra Foods and Ingredion, both carrying a Zacks Rank #2 (Buy), have growth rates of 8.00% and 11.00%, respectively.
8 Stocks with Huge Profit Potential
Just released: Driverless Cars: Your Roadmap to Mega-Profits Today. In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CAG - FREE
Get the latest research report on INGR - FREE
Get the latest research report on NUS - FREE
Get the latest research report on LW - FREE